TCM Biotech International Corp. (TPEX:4169)
Taiwan · Delayed Price · Currency is TWD 210.50
+1.00 (0.48%)
Mar 4, 2026, 9:48 AM CST
TCM Biotech International Market Cap
TCM Biotech International has a market cap or net worth of 12.37 billion as of March 3, 2026. Its market cap has increased by 266.26% in one year.
Market Cap
12.37B
Enterprise Value
11.89B
Revenue
682.40M
Ranking
n/a
PE Ratio
586.90
Stock Price
210.50
Market Cap Chart
Since May 7, 2012, TCM Biotech International's market cap has increased from 1.37B to 12.37B, an increase of 804.29%. That is a compound annual growth rate of 17.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 2, 2026 | 11.81B | 15.61% |
| Dec 31, 2025 | 10.22B | 198.79% |
| Dec 31, 2024 | 3.42B | -0.52% |
| Dec 29, 2023 | 3.44B | 128.87% |
| Dec 30, 2022 | 1.50B | -17.43% |
| Dec 30, 2021 | 1.82B | 6.17% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EirGenix | 18.28B |
| AP Biosciences | 14.59B |
| TaiMed Biologics | 13.82B |
| Ever Supreme Bio Technology | 12.75B |
| Tanvex BioPharma | 12.63B |
| Medigen Vaccine Biologics | 11.72B |
| Gongwin Biopharm Holdings | 9.91B |
| PharmaEngine | 9.02B |